SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (625)4/11/1997 6:24:00 PM
From: billkirn   of 1762
 
All: Had lunch with Bill Rastetter and then 1 1/2 hour company
presentation. Look very positive.
Company experiencing positive cash flows and will continue to
experience positive cash flows.. Once C2b8 approval company will
become profitable and has about 3 years of tax loss carry forward which will build net worth.
Presentation of C2B8 trials and the lead doctor conducting these trials was animated about the results. Real and lasting therapy
for these poor people sufferring from B-Cell Lymphoma will be available soon.
Sellers of stock from a wrap up of investment partnership..can't remember which group.
Introduced the key people just hired to develop the sales and marketing team, they will build an inhouse sales force, not sure how big..
I was very impressed with the entire group. Should be a great long term buy. Could get a great price to buy this Co. in the next few weeks and months.
Good Luck
Bill

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News